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Summary The aim of the study was to assess sleep-wake habits and disorders and
excessive daytime sleepiness (EDS) in an unselected outpatient epilepsy population.
Sleep-wake habits and presence of sleep disorders were assessed by means of a
clinical interview and a standard questionnaire in 100 consecutive patients with
epilepsy and 90 controls. The questionnaire includes three validated instruments: the
Epworth Sleepiness Scale (ESS) for EDS, SA-SDQ for sleep apnea (SA), and the
Ullanlinna Narcolepsy Scale (UNS) for narcolepsy. Sleep complaints were reported
by 30% of epilepsy patients compared to 10% of controls ( p = 0.001). The average total
sleep time was similar in both groups. Insufficient sleep times were suspected in 24%
of patients and 33% of controls. Sleep maintenance insomnia was more frequent in
epilepsy patients (52% vs. 38%, p = 0.06), whereas nightmares (6% vs. 16%, p = 0.04)
and bruxism (10% vs. 19%, p = 0.07) were more frequent in controls. Sleep onset
insomnia (34% vs. 28%), EDS (ESS 10, 19% vs. 14%), SA (9% vs. 3%), restless legs
symptoms (RL-symptoms, 18% vs. 12%) and most parasomnias were similarly frequent
in both groups. In a stepwise logistic regression model loud snoring and RL-symptoms
were found to be the only independent predictors of EDS in epilepsy patients. In
conclusion, sleep-wake habits and the frequency of most sleep disorders are similar in
non-selected epilepsy patients as compared to controls. In epilepsy patients, EDS was
predicted by a history of loud snoring and RL-symptoms but not by SA or epilepsy-
related variables (including type of epilepsy, frequency of seizures, and number of
antiepileptic drugs).
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Patients with epilepsy often complain of poor sleep
and excessive daytime sleepiness (EDS) that affect
quality of life in addition to epilepsy per se.1—3. Published by Elsevier Ltd. All rights reserved.
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changes (polysomnography) and EDS (Multiple Sleep
Latency Test, MSLT) have been frequently found.4—7
Studies on the frequency of sleep disorders in
patients with epilepsy remain, however, contradic-
tory. The frequency of obstructive sleep apnoea
(OSA) has varied between 10% and 65%8—15 and that
of restless legs syndrome/PMLS between 10% and
33%.5,16,17 The frequency of parasomnias in adult
epilepsy patients is unknown.18 In patients with
epilepsy EDS may be as high as 11—28%.10,19 While
EDS has often been referred to side effects of
antiepileptic drugs (AEDs)1 or to poor seizure con-
trol,19 insufficient sleep and concomitant sleep
disorders have also been suggested.8,9,17
Most data on the frequency of sleep disorders
and EDS in patients with epilepsy are restricted to
small study populations and to publications pub-
lished in abstract form only.20—24
The aim of this study was to assess sleep-wake
habits and the frequency of sleep disorders and
EDS in an unselected epilepsy population.Patients and methods
Over a period of 16 weeks, all patients referred to
the epilepsy outpatient clinics of the Neurology
Departments of the University Hospitals in Zu¨rich
and Berne were prospectively assessed for sleep
wake habits and disorders by means of a structured
interview and a standardised questionnaire. Only
patients older than 18 years with a confirmed diag-
nosis of epilepsy as defined according to the criteria
of International League Against Epilepsy (ILAE)
were included into the study. Patients with major
cognitive deficits (n = 3) and patients with insuffi-
cient language knowledge (n = 1) were excluded.
Healthy subjects were recruited from hospital staff
and their relatives by advertisement or mouth to
mouth propagada. All subjects participated volun-
tarily the study without being paid. A history of
neurologic, psychiatric or severe medical diseases
was excluded by interview. Subjects with sponta-
neous reports of sleep complaints and use of hyp-
notics over the last 4 weeks drugs were excluded
from the study. The sleep questionnaire includes
108 questions addressing sleep-wake habits and
complaints. The answers provide informations on
symptoms/signs suggestive of sleep apnoea (SA),
EDS, narcolepsy, different parasomnias, insomnia
and disturbances of the sleep-wake rhythm. Possi-
ble answers included ‘‘yes’’ and ‘‘no’’ or provided a
rating on a 5 point scale depending on the frequency
of occurrence (‘‘almost always’’, ‘‘often’’, ‘‘occa-
sionally’’, ‘‘seldom’’ or ‘‘never’’). For binary vari-ables, ‘‘never’’ and ‘‘seldom’’ were coded as ‘‘no’’
and ‘‘occasionally’’, ‘‘often’’ and ‘‘almost always’’
were coded as ‘‘yes’’. Three validated scores are
included in the questionnaire. The Epworth Sleepi-
ness Scale (ESS), a scale for assessment of subjec-
tive excessive daytime sleepiness based on eight
questions on the urge to sleep in various life situa-
tions.25 Each question is rated on a 4 point scale
ranging from 0 to 3 points, thus resulting in a
maximum sum score of 24 points. A cut-off score
of 10 is considered abnormal. The Sleep Apnea Scale
of the Sleep Disorders Questionnaire (SA-SDQ) is a
screening instrument for obstructive sleep apnea.26
The SA-SDQ consists of 12-items for sleep-related
breathing disorders and includes well-known risk
factors age and BMI. Cut-off scores in non-epileptic
patients are 32 for women and 36 for men (range
is 12—60) provided a sensitivity of 85% and a spe-
cificity of 72% for males and 88% and 81% for
females, respectively.15 The 11-item Ullanlinna
Narcolepsy Scale (UNS) is a widely used screening
instrument for narcolepsy. It is validated in a variety
of studies and has a high interater reability.27 A cut-
off of 14 has been shown to have a high sensitivity
(100—96%) but a variable specificity (99—56%) for
patients with narcolepsy-cataplexy.27,28 Due to
limited space the questionnaire included only a
single question related to Restless Legs Syndrome
(RLS), i.e. asking for a sensory discomfort in the
evening/night associated with an urge to move or
rub the legs. Because only three out of four diag-
nostic criteria of RLS are covered by this question
we used the term restless legs symptoms (RL-symp-
toms) instead of restless legs syndrome (RLS)
throughout the text. Clinical data including neu-
rological examination, semiology and frequency
of seizures during the last 3 months and antiepi-
leptic drugs (AEDs) were documented. Immediately
after consultation patients received the sleep
questionnaire. Three weeks after initial visit all
patients who had not sent back the questionnaire
were asked by phone to return the form. Responder
rate was 80% with a total of 100 out of 125 ques-
tionnaires completed.Statistics
Univariate and bivariate analyses: depending on
categorical or continuous variable and the distri-
bution of the data Chi-square Test/Fisher’s Exact
Test, unpaired Student’s t-test or Kruskal Wallis Test
were performed. Pearson´s Product or Spearman’s
rank correlation were performed when appropriate.
The level of significance was 0.05 in all tests. All
variables associated with the dependent variable
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Table 1 Prevalence of sleep complaints and excessive daytime sleepiness in patients with epilepsy compared to
controls
Patients with epilepsy Controls p-value
Sleep onset insomnia 34% (33/98) 28% (25/90) ns
Sleep maintenance insomnia 52% (50/97) 38% (34/90) 0.06
Fatigue 63% (63/100) 57% (56/90) ns
Excessive daytime sleepiness 37% (36/98) 32% (29/90) ns
Problems at worka (‘‘often’’) 9% (8/95) 2% (2/90) 0.06
Subjects with traffic accidents in the last 12 monthsa,b 14% (5/36) 1% (1/78) 0.008 **
Epworth Sleepiness Score (10) 19% (19/100) 14% (12/88) ns
Epworth Sleepiness Score (>14) 6% (6/100) 1% (1/90) ns
Epworth Sleepiness Score (ESS) mean (range) 5.8 (0—19) 5.1 (0—16) ns
Brackets: number of subjects.
a Associated with fatigue or EDS.
b 53% of the patients with epilepsy and 87% of controls were active drivers.(i.e. EDS/no EDS, SA/no SA) were included in a
stepwise logistic regression model to test their pre-
dictive value on the dependent variable. All tests
were calculated using SPSS (statistical package for
social sciences, Version 11.0.1).Results (see also Tables 1 and 2)
Mean age (47 years vs. 44 years) was similar in
both groups, but BMI and gender distribution sig-
nificantly differed between epilepsy patients and
controls. There were more males in the epilepsy
group (63% vs. 46%, p = 0.02) and patients had a
significantly higher BMI (25 vs. 23, p > 0.001). Epi-
lepsy was focal in 60% and generalized in 40% of
patients (idiopathic generalized epilepsies in 10%,
secondary generalized in 30%). The most commonTable 2 Prevalence of sleep disorders/sleep-related symp
Patien
Sleep apnoea syndrome
SDQ_SA15: cut-off 26 (female) 29 (male) 30% (3
SDQ_SA26: cut-off 32 (female) 36 (male) 9% (9/
Nocturnal leg cramps 25% (2
Hypnic jerks 22% (2
Restless legs symptoms 18% (1
Sleeptalking 21% (2
Bruxism 10% (9
Enuresis 0%
Nightmares 6% (6/
Shouting during sleep 4% (4/
Sleep paralysis 4% (4/
Violent acts during sleep 2% (2/
Sleepwalking 0 %
Narcolepsy (Ullanlinna Score 14) 3% (3/
Hallucinations 16% (1
Values in parenthesis are number of subjects; p-values: Chi-square Te
sleep disorders questionnaire. Cut-off score 32/36 according to26;types of seizures were simple partial (15%), com-
plex partial (46%), and generalized (in 54%). One-
third of patients had more than one seizure type.
Sixty-two of patients were seizure free within the
last 3 month, 14% had 1—2 seizures/month, 7%
3—6 seizures/month (‘‘monthly’’), 14% 7—12
seizures/month (‘‘weekly’’), and 3% had daily sei-
zures. In 39% of patients seizures predominated
or occurred only during sleep.
The patients received on average 1.4 AEDs
(range: 0—4) and the mean duration of treatment
was 13 years (range: 0—60). Most of the patients
(63%) were treated in monotherapy (i.e. carbama-
zepine: 40%, valproate: 30%, phenytoin: 22%, other:
8%), 20% received two AEDs and 12% three or more
AEDs. A minority of 5% took no AED at all. In 31% of
the patients epilepsy was considered refractory to
AEDs as defined by a failure of three or more AEDs.toms in epilepsy patients and controls
ts with epilepsy Controls p-value
0/100) 32% (16/69) ns
100) 3% (2/69) ns
5/99) 17% (15/90) ns
2/98) 15% (13/90) ns
7/96) 12% (11/90) ns
0/95) 16% (14/88) ns
/94) 19% (17/90) 0.07
0%
95) 16% (14/89) 0.04
96) 3% (3/89) ns§
96) 4% (4/86) ns
94) 2% (2/89) ns§
0% ns
100) 4% (3/69) ns
5/95) 16% (14/88) ns
st; except § Fisher’s Exact Test; SA-SDQ, sleep apnea scale of the
cut-off score 26/29 for epilepsy patients15.
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The average total sleep time (7.5 h/night) was
similar in epilepsy patients and controls, as well
as in patients with idiopathic generalized (n = 10;
7.3 h) and focal epilepsy (n = 59; 7.5 h; p = 0.7).
Three patients with epilepsy and one patient in
the control group reported an average total sleep
time of >10 h. An average total sleep time of <6 h
was reported by seven patients with epilepsy (five
with focal epilepsy) and by one control. A significant
percentage of patients (24%) and controls (33%)
reported that their time in bed on week-ends was
2 h than during week-days, suggesting the pre-
sence of a chronic sleep insufficiency.
Sleep complaints and insomnia
Subjective sleep complaints were reported by 30%
of the epilepsy patients and 10% of controls
( p = 0.001). Sleep onset insomnia was similar in
both groups (epilepsy patients 34% vs. controls
28%) and linked with RL complaints (Spearman
rho: 0.19; p = 0.01). Sleep maintenance insomnia
was, conversely, more common in epilepsy patients
(52% vs. 38%, p = 0.06) and correlated with reports
of loud snoring (Spearman rho: 0.31; p = 0.003) in
epilepsy patients and with RL-complaints in both
groups (Spearman rho: 0.26; p = 0.01)
Excessive daytime sleepiness (EDS)
The frequency of EDS was similar in both groups, as
assessed by subjective estimation (37% vs. 32%) or by
an abnormal Epworth sleepiness score (ESS  10,
19% vs. 14%).
Problems at work (9% vs. 2%, p = 0.06) and traffic
accidents related to fatigue or EDS were more
frequent in patients with epilepsy than in controls
(14% vs. 1%, p = 0.008).
The ESS correlated with age (r = 0.18, p = 0.01),
history of loud snoring (r = 0.20, p = 0.008) and
nocturnal pauses while breathing (r = 0.24, p =
0.002). A stepwise logistic regression of 157 sub-
jects including age, sex, epilepsy-controls, BMI,
hours of sleep, RL-symptoms, loud snoring, pauses
in breathing, sleep onset and sleep maintenance
the model could only explain 7% of the variance.
Only loud snoring ( p = 0.02; odds ratio 1.9; 95%-CI:
1.1—3.2) was an independent predictor of sleepi-
ness for epilepsy patients. When including SA-SDQ
(instead of loud snoring, pauses in breathing
and BMI which are included in the SA-SDQ score)
RL-symptoms had a significant predictive value ( p =
0.01, odds ratio 2.1, 95%-CI: 1.2—3.8) and the
model could explain 27% of the variance. To inves-tigate the impact of epilepsy and antiepileptic
drugs on EDS (ESS < 10 vs. ESS  10) a stepwise
logistic regression model included the following
variables: (1) type (focal vs. generalized) and fre-
quency of seizures (less than monthly vs. once a
month or more), (2) presence/absence of nocturnal
seizures, (3) etiology of epilepsy (symptomatic vs.
idiopathic), (4) duration of epilepsy, (5) number and
type of AEDs, (6) duration of AED-treatment, (7)
AED-refractory/-responsive epilepsy, (8) sex, (9)
age. None of these factors was found to be an
independent predictor of EDS.
A small proportion (7/190; 4%) of our sample
rated themselves as severely sleepy with an ESS
score (>14) comparable to that of narcoleptic
patients.27 Among them 86% (6/7) were epilepsy
patients but none of them had cataplexy. Seizure
type, seizure frequency or specific AED did not
contribute to EDS. Four of these six patients were
seizure-free and only one patient has been esti-
mated as medically refractory. However, comorbid-
ity with various sleep disorders may be relevant in
these patients: SAS in two patients, RL-symptoms in
two patients, nocturnal leg cramps in one patient
(for details see Table 3).
Sleep apnoea (SA)
Based on SA-SDQ-scale nine patients (five men, four
women) and two controls (one men, one woman)
had an abnormal score (>32 for female; >36 for
male26) suggestive of SA. Using a less conservative
cut-off score recently suggested for epilepsy
patients15 30% of epilepsy patients (16 men, 14
women) and 23% of controls (10 male, 6 female)
met the chosen criteria for SA. All but one of these
epilepsy patients were older than 50 years. BMI was,
conversely, similar in epilepsy patients with and
without SA.
Restless legs symptoms (RL-symptoms)
The frequency of RL-symptoms, as assessed by a
single question (see Section ‘Methods’), did not
differ between patients (18%) and controls (12%).
There was a significant correlation between RL-
symptoms and age (r = 0.35; p < 0.001). In addition,
RL-symptoms contribute to EDS in epilepsy patients
as reflected by a higher mean ESS (5.2 vs. 8.1;
unpaired t-test p = 0.01) and a higher percentage
of patients with an ESS  10 (13% vs. 39%; p = 0.01).
Narcolepsy
An abnormal UNS score (cut-off 14 points) was seen
in 3% of patients and 4% of controls. These high
UNS scores were due in all but one subject to the
subset of questions addressing EDS. In none of the
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Table 3 Epilepsy patients with severe daytime sleepiness
No Sex Age Sleep time
(h)
Epilepsy AED ESS UNS UNS cataplexy subscalea
involved muscles/falls
SA-SDQ Primary sleep
disorder
Knee Jaw Head Falls
9 F 59 7 Duration in years: 2; type of seizure:
CPS; seizure-frequencyb: 1—2; nocturnal
seizures: none; medically refractory: no
None 19 20 3 1 1 1 29 RL-symptoms
15 M 33 9 Duration in years: 31; type of seizures:
CPS, SG; seizure frequency: weekly;
nocturnal seizures: often; medically
refractory: yes
DPH VPA LTG LEV 16 13 1 1 1 2 22 Bruxism
17 F 60 7.5 Duration in years: 8; type of seizure:
CPS; seizure free; nocturnal seizures:
none; medically refractory: no
DPH VPA 15 15 4 3 5 2 30 SAS, sleep talking
(‘‘occasionally’’)
33 F 43 6 Duration in years: 11; type of seizure:
CPS; seizure free; nocturnal seizures:
rare; medically refractory: no
CBZ 19 7c n.a. n.a. n.a. n.a. 11 Nocturnal leg
cramps (‘‘often’’),
RL-symptoms
69 M 68 9.5 Duration in years: 2; type of seizure:
EFA; seizure free; nocturnal seizures:
none; medically refractory: no
VPA 18 18 2 1 1 1 40 SAS
73 M 47 n.a. Duration in years: 11; type of seizure:
SG; seizure free; nocturnal seizures:
none; medically refractory: no
VPA 18 n.a. 1 1 1 2 21 None
F = female, M = male, sleep time = nocturnal sleep time in hours.
a Frequency of involved muscles/falls: 1 = ‘‘never’’, 2 = ‘‘ rarely’’, 3 = ‘‘occasionally’’, 4 = ‘‘often’’, 5 = ‘‘almost always’’; AED = antiepileptic drugs, ESS = Epworth Sleepiness Scale,
UNS = Ullanlinna Narcolepsy Scale; SA-SDQ = Sleep Apnea Scale of the Sleep Disorders Questionnaire; RL-symptoms = restless legs symptoms, SAS = sleep apnea syndrome; n.a. = not
applicable.
b Seizure frequency during the past 3 month.
c Without cataplexy subscale.
304 R. Khatami et al.patients/controls the diagnosis of narcolepsy was
confirmed after clinical assessment.
Parasomnias
Overall, 60% in the epilepsy patients and 58% of
the controls reported parasomnias. Sleep-wake
transition parasomnias (night leg cramps, sleep
starts, sleeptalking) were most commonly
reported.
The frequency of bruxism (19% vs. 10%, p = 0.07)
and nightmares (16% vs. 6%, p = 0.04) was higher in
controls than in epilepsy patients.
Symptoms suggestive ofNREM-parasomnias (inclu-
ding sleepwalking, sleep terror) andREM-sleepbeha-
vior disorder (violent acts in sleep or shouting during
sleep) were rare in both groups (see Table 2).Discussion
The present study confirms a higher frequency of
subjective sleep disturbances,2,17,19 but, with few
exceptions (sleep maintenance insomnia, night-
mares, and bruxism), similar sleep-wake habits
and frequency of sleep disorders in a non-selected
population of epilepsy patients as compared to
controls. Although our control group recruited form
hospital staff may be at least somehow biased by
higher sleep complaints, the sleep-wake habits
and prevalence of sleep disorders were similar to
those reported in a study performed in an emp-
loyed Swiss population of 1473 clerks of the Bern
main post office.29 In addition the estimated fre-
quencies of EDS (14%), SA (3%), RL-symptoms (12%)
and insomnia (28—38%) are similar to those
reported in the literature.
Conversely, our results in the epilepsy patients
contrast with previous studies, in which higher fre-
quencies of EDS and/or sleep disorders were
found.3,4,9,15,20,21,23 Several factorsmay explain this
discrepancy. First, the inclusion of selected patients
(i.e. with distinct epilepsy syndromes2,3,20 or medi-
cally refractory patients9) or patients already
referred to a sleep center for diagnostic work of
sleep disorders15,20 may have led to an overestima-
tion of EDS and sleep disorders in previous works.
Second, we used validated scales for the assessment
of EDS and SA.3,4 Third, the sample size was much
higher in the present analysis as compared to some
of previous studies.3,4,20
Excessive daytime sleepiness
Our study confirms that the frequency EDS is not
increased in epilepsy patients as compared to
controls.2,10,19Data on predictors of EDS in patients with epi-
lepsy are contradictory. We found that EDS in epi-
lepsy patients was predicted by a history of loud
snoring, and by RL-symptoms but not by SA or
epilepsy-related variables such as frequency of
seizures and antiepileptic treatment. Malow
et al. found that SA and RL-symptoms have a stro-
nger impact on EDS than epilepsy related factors.10
In contrast, SA and seizure frequency but not
RL-symptoms were predictors EDS in the study of
Manni et al.19
In a recent Dutch the epilepsy group showed
higher scores in most subscales of sleep disorders
(including SA, PLMS, narcolepsy, snoring).2
These differences may be explained also by the
selection of the control group. Malow et al. com-
pared epilepsy patients to other neurological
patients.10 The latter group is known to have higher
frequency of sleep disorders.30,31 The control group
in Manni’s study is not described in detail.19
A small subgroup of our epilepsy patients had
severe EDS comparable to that of patients with
narcolepsy (ESS > 14).27 Most of them reported
symptoms of RL-symptoms and were overweight
older males presenting with loud habitual snoring
(but no witnessed pauses in breathing) suggestive
for SAS. Again, none of the epilepsy or AED related
factors were associated with EDS.
Despite these results, epilepsy- and AED-related
factors should not be neglected as potential con-
tributors of EDS in single epilepsy patients. The
effect of AEDs and seizures (daytime and noc-
turnal) and type of epilepsy on sleep architecture
has been already demonstrated.1,6,7,32,33 Sleep
disorders, AEDs and seizure frequencies may influ-
ence each other. AEDs canworsen SAS and vice versa
sleep disorder potential increase neuronal excit-
ability due to its detrimental effect on sleep archi-
tecture in relation to sleep disorders and EDS.
Adequate treatment of primary sleep disorders
at least in sleep apnea syndrome in single patients
did not only improve sleep quality and excessive
daytime sleepiness but also potentially reduced
seizure frequency.12,13,16,34
Restless legs symptoms (RL-symptoms)
Although frequency of RL-complaints was similar in
epilepsy patients and controls, the contribution of
restless legs symptoms to EDS in epilepsy patients is
clinically relevant, as Restless Legs Syndrome (RLS)
is a treatable sleep disorder. A similar high fre-
quency of estimated RL-symptoms based on one
question was found by Malow et al.10 Reports on a
higher comorbidity of Restless Legs Syndrome in
epilepsy patients are confined to case reports to
Epilepsy and sleep 305the occurrence of RLS under specific AED
regimes.35,36 Therefore, clinicians should confirm
diagnosis of RLS by using detailed interview or
standardized questionaires and consider both dopa-
minergic medication and/or a change of AED as
therapeutical options.
Sleep apnea (SA)
The similar frequency of SA in epilepsy patients
and controls in this study is consistent with a study
of a series of unselected epilepsy sample,16 but
contrasts recent results of higher frequencies of
OSA in selected9 and unselected epilepsy patients.8
Our epilepsy patients with suspected SA had simi-
lar risk factors for SA as our controls with the
exception of a higher BMI. None of the epilepsy-
or AED-related factors contributed independently
to SA. This is consistent with the notion that in
epilepsy patients established risk factors are asso-
ciated with SA.
Parasomnias
For most parasomnias no differences in frequency
were found between epilepsy patients and controls.
This is in contrast with the frequent association
between parasomnias and epilepsy in childhood.37
In fact, several authors reported a high frequency of
arousal disorders (sleep terror, sleepwalking) and
headbanging in epileptic children.38
The higher frequency of sleep complaints in our
epilepsy sample may be related to psychiatric
disorders. Comorbidity with anxiety and depres-
sion is higher in patients with epilepsy than in the
general population39 and would also explain the
high frequency of sleep maintenance insomnia in
our study. Unfortunately, we did not assess mood
disorders and anxiety disorders in our sample.
Another limitation of our study relates to the
absence objective sleep tests (i.e. polysomnogra-
phy, MSLT) to confirm suspected sleep disorders
and the presence/severity of EDS.References
1. Bazil CW. Sleep epilepsy. Curr Opin Neurol 2000;13:171—5.
2. de Weerd A, de Haas S, Otte A, Trenite DK, van Erp G, Cohen
A, et al. Subjective sleep disturbance in patients with partial
epilepsy: a questionnaire-based study on prevalence and
impact on quality of life. Epilepsia 2004;45:1397—404.
3. Hoeppner JB, Garron DC, Cartwright RD. Self-reported
sleep disorder symptoms in epilepsy. Epilepsia 1984;25:
434—7.4. Drake Jr ME, Weate SJ, Newell SA, Padamadan H, Pakalnis A.
Multiple sleep latency tests in epilepsy. Clin Electroencepha-
logr 1994;25:59—62.
5. Newell SA, Drake Jr ME. Sleep apnea and periodic leg
movements in epilepsy. Clin Electroencephalogr 1994;25:
153—5.
6. Crespel A, Baldy-Moulinier M, Coubes P. The relationship
between sleep and epilepsy in frontal and temporal lobe
epilepsies: practical and physiopathologic considerations.
Epilepsia 1998;39:150—7.
7. Crespel A, Coubes P, Baldy-Moulinier M. Sleep influence on
seizures and epilepsy effects on sleep in partial frontal and
temporal lobe epilepsies. Clin Neurophysiol 2000;111(Suppl
2):54—9.
8. Manni R, Terzaghi M, Arbasino C, Sartori I, Galimberti CA,
Tartara A. Obstructive sleep apnea in a clinical series of adult
epilepsy patients: frequency and features of the comorbidity.
Epilepsia 2003;44:836—40.
9. Malow BA, Levy K, Maturen K, Bowes R. Obstructive sleep
apnea is common in medically refractory epilepsy patients.
Neurology 2000;55:1002—7.
10. Malow BA, Bowes RJ, Lin X. Predictors of sleepiness in
epilepsy patients. Sleep 1997;20:1105—10.
11. Vaughn BV, D’Cruz OF. Obstructive sleep apnea in epilepsy.
Clin Chest Med 2003;24:239—48.
12. Devinsky O, Ehrenberg B, Barthlen GM, Abramson HS, Luciano
D. Epilepsy and sleep apnea syndrome [comment]. Neurology
1994;44:2060—4.
13. Vaughn BV, D’Cruz OF, Beach R, Messenheimer JA. Improve-
ment of epileptic seizure control with treatment of obstruc-
tive sleep apnoea. Seizure 1996;5:73—8.
14. Beran RG, Plunkett MJ, Holland GJ. Interface of epilepsy and
sleep disorders. Seizure 1999;8:97—102.
15. Weatherwax KJ, Lin X, Marzec ML, Malow BA. Obstructive
sleep apnea in epilepsy patients: the Sleep Apnea Scale of the
Sleep Disorders Questionnaire (SA-SDQ) is a useful screening
instrument for obstructive sleep apnea in a disease-specific
population. Sleep Med 2003;4:517—21.
16. Malow BA, Fromes GA, Aldrich MS. Usefulness of polysomno-
graphy in epilepsy patients. Neurology 1997;48:1389—94.
17. Foldvary-Schaefer N. Sleep complaints and epilepsy: the role
of seizures, antiepileptic drugs and sleep disorders. J Clin
Neurophysiol 2002;19:514—21.
18. DykenME, Yamada T, Lin-Dyken DC. Polysomnographic assess-
ment of spells in sleep: nocturnal seizures versus parasom-
nias. Semin Neurol 2001;21:377—90.
19. Manni R, Politini L, Sartori I, Ratti MT, Galimberti CA, Tartara
A. Daytime sleepiness in epilepsy patients: evaluation by
means of the Epworth Sleepiness Scale. J Neurol
2000;247:716—7.
20. Foldvary-Schaefer N, Marsilio D, Qureshi F, Golish J, Dinner D.
Comparison of daytime sleepiness in patients with epilepsy
and obstructive sleep apnea measured by the Epworth slee-
piness scale. Sleep Res 1997;26:552.
21. Vaughn BV, Miller MT, D’Cruz OF, Messenheimer J. Prevalence
of sleep complaints in patients with epilepsy: application of
the Epworth sleepiness scale. Sleep Res 1996;25:453.
22. Frost M, Malow B, Aldrich M. A survey of sleep disorders in
epilepsy patients. Neurology 1996;46:A120.
23. Sanchez de Leon I, Foldvary N, Marsilio D, Dinner DS. Effect of
seizure frequency and antiepileptic drugs on daytime alert-
ness as measured by Epworth Sleepiness Scale in patients
with epilepsy. Epilepsia 1997;38:56.
24. Armaganijan AF, Ehrhardt MV, Taxeira V. Epworth Sleepiness
Scale (ESS) in partial seizure patients. Sleep 2000;23:349.
25. Johns MW. A new method for measuring daytime sleepiness:
the Epworth Sleepiness Scale. Sleep 1991;14:540—5.
306 R. Khatami et al.26. Douglass AB, Bornstein R, Nino-Murcia G, Keenan S, Miles L,
Zarcone JrVPet al.TheSleepDisordersQuestionnaire. I: Crea-
tion andmultivariate structure of SDQ. Sleep 1994; 17:160—7.
27. Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K,
Koskimies S, et al. The prevalence of narcolepsy: an epide-
miological study of the Finnish twin cohort. Ann Neurol
1994;35:709—16.
28. Sturzenegger Ch., Bassetti CL. The clinical spectrum of nar-
colepsy with cataplexy: a reappraisal. J Sleep Res 2004;
13:395—406.
29. Schmitt BE, Gugger M, Augustiny K, Bassetti C, Radanov BP.
Prevalence of sleep disorders in an employed Swiss popula-
tion: results of a questionnaire survey. Schweiz Med
Wochenschr 2000;27(130):772—8.
30. Larner AJ. Obstructive sleep apnoea syndrome presenting in
a neurology outpatient clinic. Int J Clin Pract 2003;57: 150—2.
31. Happe S. Excessive daytime sleepiness and sleep distur-
bances in patients with neurological diseases: epidemiology
and management. Drugs 2003;63:2725—37.
32. Legros B, Bazil CW. Effects of antiepileptic drugs on sleep
architecture: a pilot study. Sleep Med 2003;4:51—5.33. Khatami R, Siegel AM, Bassetti CL. Hypersomnia in an epi-
lepsy patient treated with levetiracetam. Epilepsia 2005;
46:588—9.
34. Malow BA,Weatherwax KJ, Chervin RD, Hoban TF, Marzec ML,
Martin C, et al. Identification and treatment of obstructive
sleep apnea in adults and children with epilepsy: a prospec-
tive pilot study. Sleep Med 2003;4:483—94.
35. Chen JT, Garcia PA, Alldredge BK. Zonisamide-induced rest-
less legs syndrome. Neurology 2003;60:147.
36. Drake ME. Restless legs with antiepileptic drug therapy. Clin
Neurol Neurosurg 1988;90:151—4.
37. Oldani A, Zucconi M, Asselta R, Modugno M, Bonati MT, Dalpra
L, et al. Autosomal dominant nocturnal frontal lobe epilepsy.
A video-polysomnographic and genetic appraisal of 40
patients and delineation of the epileptic syndrome. Brain
1998;121:205—23.
38. Stores G, Wiggs L, Campling G. Sleep disorders and their
relationship to psychological disturbance in children with
epilepsy. Child Care Health Dev 1998;24:5—19.
39. Jackson MJ, Turkington D. Depression and anxiety in epilepsy.
J Neurol Neurosurg Psych 2005;76(Suppl I):45—7.
